Moderna, Inc.
Close on Nov 2, 2026Market cap $88.16BP/E –Yield –
Moderna Approved commercial products on market by Quarter
Approved commercial products on market (products)
Moderna Approved commercial products on market: 4.00 products in Q2 2026, up 33.3% from a year earlier. That is the highest of the 9 quarters on record here.
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-07-31) ↗
Reported in Form 10-Q / 10-K Note 1 (Description of Business).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Approved commercial products on market (products) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 4.00 | +33.3% | Form 10-Q (filed 2026-07-31) ↗ |
| Q1 2026 | Mar 31, 2026 | 3.00 | +50.0% | Form 10-Q (filed 2026-05-01) ↗ |
| Q4 2025 | Dec 31, 2025 | 3.00 | +50.0% | Form 10-K (filed 2026-02-20) ↗ |
| Q3 2025 | Sep 30, 2025 | 3.00 | +50.0% | Form 10-Q (filed 2025-11-06) ↗ |
| Q2 2025 | Jun 30, 2025 | 3.00 | +50.0% | Form 10-Q (filed 2025-08-01) ↗ |
| Q1 2025 | Mar 31, 2025 | 2.00 | – | Form 10-Q (filed 2025-05-01) ↗ |
| Q4 2024 | Dec 31, 2024 | 2.00 | – | Form 10-K (filed 2025-02-21) ↗ |
| Q3 2024 | Sep 30, 2024 | 2.00 | – | Form 10-Q (filed 2024-11-07) ↗ |
| Q2 2024 | Jun 30, 2024 | 2.00 | – | Form 10-Q (filed 2024-08-01) ↗ |
Cite this data
StockData. (2026). Moderna Approved commercial products on market, quarterly Q2 2024–Q2 2026 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/num-commercial-products
See every metric in the Moderna KPI table. Data updated Nov 3, 2026.